Literature DB >> 10495068

Late-onset schizophrenia: epidemiology, diagnosis, management and outcomes.

P A Wynn Owen1, D J Castle.   

Abstract

The onset of schizophrenia for the first time in late life has been considered rare, and the nosology of the late-onset functional psychoses remains contentious. However, it is clear that a significant proportion of individuals with a diagnosis of schizophrenia do have the first onset of the illness in late and very late life. The clinical presentation of such patients shows some differences from patients with early-onset disease, particularly in having a lower prevalence of premorbid dysfunction, negative symptoms and formal thought disorder. The longitudinal course is variable, possibly a reflection of aetiological heterogeneity. Atypical antipsychotic agents would appear to have significant benefits in the treatment of this group of patients, given the particular vulnerability of the elderly to extrapyramidal adverse effects, notably tardive dyskinesia.

Entities:  

Mesh:

Year:  1999        PMID: 10495068     DOI: 10.2165/00002512-199915020-00002

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  32 in total

1.  Senile schizophrenia.

Authors:  F FISH
Journal:  J Ment Sci       Date:  1960-07

2.  A chart review study of late-onset and early-onset schizophrenia.

Authors:  G D Pearlson; L Kreger; P V Rabins; G A Chase; B Cohen; J B Wirth; T B Schlaepfer; L E Tune
Journal:  Am J Psychiatry       Date:  1989-12       Impact factor: 18.112

3.  Clozapine in Older Patients With Psychosis and Behavioral Disruption.

Authors:  Carl Salzman; Bernard Vaccaro; Jonathan Lieff; Anthony Weiner
Journal:  Am J Geriatr Psychiatry       Date:  2012-08-08       Impact factor: 4.105

Review 4.  The epidemiology of late-onset schizophrenia.

Authors:  D J Castle; R M Murray
Journal:  Schizophr Bull       Date:  1993       Impact factor: 9.306

5.  Epidemiology of persecutory ideation in an elderly population in the community.

Authors:  R Christenson; D Blazer
Journal:  Am J Psychiatry       Date:  1984-09       Impact factor: 18.112

6.  Can schizophrenia begin after age 44?

Authors:  P Rabins; S Pauker; J Thomas
Journal:  Compr Psychiatry       Date:  1984 May-Jun       Impact factor: 3.735

7.  A controlled family study of late-onset non-affective psychosis (late paraphrenia).

Authors:  R J Howard; C Graham; P Sham; J Dennehey; D J Castle; R Levy; R Murray
Journal:  Br J Psychiatry       Date:  1997-06       Impact factor: 9.319

8.  Environmental and hereditary factors in the schizophrenias of age ("late paraphrenia") and their bearing on the general problem of causation in schizophrenia.

Authors:  D W KAY; M ROTH
Journal:  J Ment Sci       Date:  1961-07

9.  Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.

Authors:  D V Jeste; M P Caligiuri; J S Paulsen; R K Heaton; J P Lacro; M J Harris; A Bailey; R L Fell; L A McAdams
Journal:  Arch Gen Psychiatry       Date:  1995-09

Review 10.  Overview of depression and psychosis in Alzheimer's disease.

Authors:  R E Wragg; D V Jeste
Journal:  Am J Psychiatry       Date:  1989-05       Impact factor: 18.112

View more
  5 in total

1.  Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study.

Authors:  Marie Kim Wium-Andersen; David Dynnes Ørsted; Børge Grønne Nordestgaard
Journal:  Schizophr Bull       Date:  2013-08-31       Impact factor: 9.306

Review 2.  Amisulpride: a review of its use in the management of schizophrenia.

Authors:  M P Curran; C M Perry
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Long-acting injectable antipsychotics in the elderly: guidelines for effective use.

Authors:  Prakash S Masand; Sanjay Gupta
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

4.  Psychosis risk as a function of age at onset: a comparison between early- and late-onset psychosis in a general population sample.

Authors:  Sebastian Köhler; Jim van Os; Ron de Graaf; Wilma Vollebergh; Frans Verhey; Lydia Krabbendam
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-03-12       Impact factor: 4.328

5.  Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity.

Authors:  C S Weickert; Y Tiwari; P R Schofield; B J Mowry; J M Fullerton
Journal:  Transl Psychiatry       Date:  2012-04-17       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.